Skip to main content
OpenTrials
Completed

NCT Number: NCT03957460

Accuracy of Continuous and Non-invasive Hemoglobin Monitoring

The primary purpose of this observational study is to investigate the accuracy on the continuous and non-invasive hemoglobin monitoring during laparoscopic gastrectomy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine

Suwon, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • laparoscopic gastrectomy under general anesthesia

Exclusion criteria

  • atypical hemoglobin disease, infective state, cardiovascular disease, peripheral vascular disease

Treatment and study plan

SpHb monitoring

Other

Subjects receive the continuous and noninvasive hemoglobin monitoring (SpHb monitoring).

Primary outcomes

  1. difference between SpHb value in g/dL and SaHb value in g/dL (SpHb - SaHb)

    Time frame: from the start of anesthesia to the end of anesthesia, an average 2 hours

    SpHb value in g/dL is measured by co-oxymetry, and SaHb value in g/dL is measured by blood sampling.

Sponsors and collaborators

Lead sponsor

Ajou University School of Medicine

Other

Registry information

Official study title

Accuracy of Continuous and Non-invasive Hemoglobin Monitoring During Laparoscopic Gastrectomy: Observational Study

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
May 21, 2019
Registry last updated
May 11, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.